On August 11 2023, YEO HIAP SENG ($SGX:Y03) reported total revenue of SGD 181.1 million for the second quarter ending June 30 2023, representing a slight decrease of 0.1% compared to the same period in the previous year. Net income for the quarter was SGD 3.3 million, a significant year-over-year increase of 178.3%.
YEO HIAP SENG’s financials have been analyzed by GoodWhale. It has a high health score of 7/10 with regard to its cashflows and debt, indicating that it is capable to sustain future operations in times of crisis. The Star Chart also revealed that while YEO HIAP SENG is strong in assets, it is only medium in dividend and weak in growth and profitability. As such, it has been classified as ‘rhino’, a type of company we conclude that has achieved moderate revenue or earnings growth. This type of company may be of interest to investors who are looking for companies with strong fundamentals but may not offer attractive returns in the short term. These investors are usually looking for long-term investments that are more stable and reliable. More…
Risk Rating Analysis
Star Chart Analysis
About the Company
Ownership (Institutional/ Fund Holdings)
Below shows the total revenue, net income and net margin for Y03. More…
Income Statement Reports (Yearly/ Quarterly/ LTM)
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Y03. More…
Cash Flow Statement (Yearly/ Quarterly/ LTM)
Cash Flow Supplement
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Y03. More…
Balance Sheet (Yearly/ Quarterly)
Balance Sheet Supplement
||Book Value Per Share
Key Ratios Snapshot
Some of the financial key ratios for Y03 are shown below. More…
Income Statement Ratios
Balance Sheet Ratios
Cash Flow Ratios
Other Supplementary Items
|3Y Rev Growth
||3Y Operating Profit Growth
Yeo Hiap Seng Ltd is a food and beverage company headquartered in Singapore. The company was founded in 1931 and is one of the leading food and beverage companies in Southeast Asia. The company’s products include soy sauce, curry sauce, chili sauce, ketchup, and more. The company has a wide variety of products that are popular in Southeast Asia. Yeo Hiap Seng Ltd has a strong presence in Singapore, Malaysia, Indonesia, and Thailand. The company competes with Ma San Group Corp, Kawan Food Bhd, Red Sena Bhd, and other leading food and beverage companies in Southeast Asia.
– Ma San Group Corp ($HOSE:MSN)
Sanofi, a French multinational pharmaceutical company, is one of the world’s largest pharmaceutical companies. With a market capitalisation of over €112 billion and a return on equity of 39.47%, it is a major player in the global pharmaceutical industry. The company manufactures and markets a wide range of prescription and over-the-counter drugs, covering everything from diabetes to oncology. Sanofi is also a significant player in the vaccines market, with a portfolio that includes some of the world’s most important vaccines, such as the influenza vaccine.
Kawan Food Berhad is one of the leading food manufacturers in Malaysia with a market capitalization of RM840 million as of end 2022. The company is involved in the manufacture and marketing of food products under the brand names of ‘Kawanku’ and ‘Kawan Lama’. Its products include frozen food, biscuits, snacks and confectionery. The company has a strong presence in the domestic market with a market share of approximately 20%. It also exports its products to over 30 countries worldwide.
Red Sena Bhd is a publicly traded company with a market capitalization of 505 million as of 2022. The company has a return on equity of 47.26%. Red Sena Bhd is involved in the business of providing telecommunications and information technology services.
YEO HIAP SENG’s second quarter earnings results for the period ending June 30, 2023 showed total revenue of SGD 181.1 million, a slight decrease of 0.1% year over year. Net income for the period was SGD 3.3 million, a substantial increase of 178.3% year over year. This positive financial result is an encouraging sign for investors, as it indicates that YEO HIAP SENG is continuing to experience financial growth despite the global economic instability created by the pandemic.
Additionally, YEO HIAP SENG’s low-risk strategies appear to be paying off, with its conservative approach to investments leading to long-term stability and a strong return on investment. With this strong performance and its commitment to conservative investments, YEO HIAP SENG is well positioned to continue to deliver strong returns for its investors moving forward.